INNOVATE

Sepsis program

 

 

 

 

The Sepsis program gathers specific R&D projects built to improve septic patients’ hospital care.

Read the press release on 2011/04/26 - Lyonbiopole carries out its Sepsis program to fight against severe infectious conditions in collaboration with the 3 University Hospital of the Rhône-Alpes region

 

It is based on a regional clinical network. This program results from Lyonbiopole’s workshop and is coordinated by Lyonbiopole.

 

Go to Governance

 

 

 

 

 

 

 

Partners
The clinical network is composed by:

 

Logo Grenoble

Grenoble University Hospital
Intensive Care Unit
Pr Jean-François TIMSIT

 

Logo HCL

Lyon Civil Hospitals
Lyon Sud’s North Intensive Care Unit
Dr Alain LEPAPE

 

Logo St Etienne

Saint Etienne University Hospital
Intensive Care Unit
Pr Fabrice ZENI

 

Schéma Sepsis FR

 

See the operating process

 

 

 

 

 

The Sepsis program is supported by:

 

Soutien programme sepsis

 

Interested in Sepsis program ?

 

Build your project :
Sarah Crochon
Innovation Project Manager - Sepsis Program
Phone.: +33 (0)4 72 76 53 35

Port : 06 43 57 42 84
Email : sarah.crochon@lyonbiopole.com
www.lyonbiopole.com



Lyonbiopole
Bâtiment Domilyon
321, avenue Jean Jaurès
69007 LYON

 

Logo_Sepsis 2011

 



They speak about...


« Innovations by biotech firms still take too long to reach major pharmaceutical companies, despite the growing needs of industrial firms and their interest in these breakthroughs in the area of personalized treatment. One of the main reasons is that start ups lack networks and visibility in the eyes of these large industrial groups. These two complementary players thus need a catalyst to create meetings, pass on information and contact one another. This is what World Competitive Clusters like Lyonbiopole do. ImmunID has benefited from this effective support, and we have had excellent results in 2008 and 2009, signing contracts with several firms which are leaders in their field, such as Sanofi Pasteur. In the end, Lyonbiopole is an organization which plays an active role in setting up and giving impetus to future high potential R&D projects in the health sphere. »


Nicolas Pasqual

ImmunID Technologies - Ph.D. CEO

DOCUMENTATION | CONTACT | SEARCH